Edwards Lifesciences Corporation — Net Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/2c1232f5-71ff-4445-97fa-444d06cbb255/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $1.1B | 2025-01-01 – 2025-12-31 | evidence 0001099800-26-000009 |
| FY 2024 | $4.2B | 2024-01-01 – 2024-12-31 | evidence 0001099800-25-000005 |
| FY 2023 | $1.4B | 2023-01-01 – 2023-12-31 | evidence 0001099800-24-000004 |
| FY 2022 | $1.5B | 2022-01-01 – 2022-12-31 | evidence 0001099800-24-000004 |
| FY 2021 | $1.5B | 2021-01-01 – 2021-12-31 | evidence 0001099800-24-000004 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Edwards Lifesciences Corporation — all facts · Revenue · Operating Income